Delivery Order SPE2DR25D1017-SPE2DR26F9APF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,895.98 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. This delivery order was issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,396.04 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical delivery under AmerisourceBergen's broader federal medical supply relationships. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,759.42 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,544.36 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 8, 2025, with a completion date of August 11, 2025. This firm fixed-price delivery order is a competitive award with no set-aside designation and represents a child contract under AmerisourceBergen's broader relationship with federal medical procurement. The product will be performed at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $4,455.71 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,770.40 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,604.53 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 Tablet 28s on September 25, 2025, with completion anticipated by September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply requirement fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The award is part of AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $1,171.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count units. This is a non-set-aside contract with a completion date of June 3, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in quantities of 28 units, with a ceiling value of $4,280.10. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively. The contract is expected to be completed by December 12, 2025, and the product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9APFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,534.67 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 Tablet 28s on December 1, 2025, with an ultimate completion date of December 2, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of medications and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling varied pharmaceutical needs through delivery orders with firm fixed pricing, positioning it as a key supplier within the Defense Logistics Agency's medical supply chain and supporting the Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/30/25 |